November 24, 2022

ImmuneWatch is named as a Deep Tech Pioneer by Hello Tomorrow

We’re thrilled to announce we’ve been named a Deep Tech Pioneer by Hello Tomorrow! From more than 4000 of applications our solution has been selected by a team of experts who saw real potential in our technology.

As a result we will be attending the Hello Tomorrow Global Summit in March 2023, a cornerstone event dedicated to celebrating and accelerating deep tech innovation: connecting key people, bringing solutions from lab to market and strengthening the deep tech investment network.

Come and join us:

Get your tickets

Stay up to date

Subscribe to our newsletter to receive useful tips and information.

Thank you! Your submission has been received!

Oups ! Un problème s'est produit lors de l'envoi du formulaire.

Recommended articles

March 23, 2024

Selected to pitch at Knowledge for Growth

We are excited that our abstract “Implementing Artificial Intelligence in the vaccine development process” has been selected for a pitch at Knowledge for Growth!

March 23, 2024

New academic paper: Using TCR sequencing and AI to shed light on the intricate dynamics of our immune system during SARS-CoV-2 infection

A new study co-authored by ImmuneWatch’s co-founders, Pieter Meysman, Benson Ogunjimi and Kris Laukens, analysed the role of T cells in the severity of COVID-19 and the specificity of their response to SARS-CoV-2, demonstrating the power of AI in unravelling this complex immune response.